Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Cladribine in Patients With Mantle Cell Lymphoma

NCT00002879

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

CCOP - Illinois Oncology Research Association Peoria, Illinois, United States

CCOP - Carle Cancer Center Urbana, Illinois, United States

CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States

View all 21 locations

View Trial Details

Completed

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01421667

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists Oxnard, California, United States

Stanford Cancer Center Stanford, California, United States

View all 34 locations

View Trial Details

Completed

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00683046

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Aplastic, +41 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma

NCT01486277

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Pittsburgh, Pennsylvania, United States

Nantes, France

Paris, France

Pessac, France

View all 13 locations

View Trial Details

Completed

Acupuncture for Chemo-Induced Peripheral Neuropathy

NCT00891618

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

NCT00025662

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

NCT00634179

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Emory University Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Completed

Fungemia in Hematologic Malignancies

NCT02451592

Conditions: Acute Leukemia, Bacterial Infections and Mycoses, Blood Protein Disorders, +28 more
Locations: Catholic University of Sacred Heart Rome, Italy

View Trial Details

Completed

Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma

NCT00901069

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
Locations: University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN)

NCT00517530

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Créteil, France

Le Mans, France

Lille, France

Marseille, France

View all 16 locations

View Trial Details